Kewaunee Scientific (NASDAQ:KEQU – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Saturday.
Kewaunee Scientific Stock Performance
NASDAQ:KEQU opened at $37.90 on Friday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 2.00 and a current ratio of 2.53. The stock has a market capitalization of $108.77 million, a PE ratio of 6.08 and a beta of 0.73. Kewaunee Scientific has a fifty-two week low of $16.51 and a fifty-two week high of $55.62. The company has a fifty day moving average of $34.92 and a two-hundred day moving average of $41.56.
Kewaunee Scientific (NASDAQ:KEQU – Get Free Report) last released its quarterly earnings results on Wednesday, September 11th. The technology company reported $0.93 earnings per share for the quarter. Kewaunee Scientific had a net margin of 9.13% and a return on equity of 25.87%. The firm had revenue of $48.39 million during the quarter.
Institutional Inflows and Outflows
About Kewaunee Scientific
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
See Also
- Five stocks we like better than Kewaunee Scientific
- Which Wall Street Analysts are the Most Accurate?
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Retail Stocks Investing, Explained
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.